UpHealth reached a definitive agreement to divest Innovations Group, including its compounding pharmacy subsidiary, MedQuest Pharmacy, Inc., to Belmar Pharma Solutions for approximately $56 million in gross proceeds. The transaction is expected to close in May and is subject to customary closing conditions. Bourne Partners acted as exclusive financial advisor to UpHealth on the transaction.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UPH:
